Federal Register Notices > Notice of Application 2003 > Penick, Corporation

Information and Legal Resources Banner

Notice of Application - 2003


[Federal Register: August 5, 2003 (Volume 68, Number 150)]
[Notices]
[Page 46226-46227]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05au03-89]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 2, 2003, Penick, Corporation, 158 Mount Olivet Avenue, Newark, New Jersey 07114, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug Schedule
Cocaine (9041) II
Codeine (9050) II
Dihydrocodeine (9120) II
Oxycodone (9143) II
Hydromorphone (9150) II
Diphenoxylate (9170) II
Ecgonine (9180) II
Hydrocodone (9193) II
Morphine (9300) II
Thebaine (9333) II
Oxymorphone (9652) II

[[Page 46227]]

The firm plans to manufacture bulk controlled substances and non-controlled flavor extracts.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Federal Register Representative, Office of Chief Counsel (CCD) and must be filed no later than October 6, 2003.

Dated: July 22, 2003.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 03-19809 Filed 8-4-03; 8:45 am]

BILLING CODE 4410-09-M

NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).

DEA: Drug Enforcement Administration Home